The U.S. Food and Drug Administration (FDA) has approved first-time generic formulations of glimepiride 1-, 2-, and 4-mg tablets and first-time doses of 3-, 6-, and 8-mg tablets for the management of diabetes mellitus; amlodipine besylate 2.5-, 5-, and 10-mg [base] tablets for the treatment of hypertension and coronary artery disease; and ramipril 1.25-, 2.5-, 5-, and 10-mg capsules for the treatment of hypertension and reduction of cardiovascular risk.Technorati Tags: Amaryl, Norvasc, Altace
I'm Dr. Joshua Schwimmer, a nephrologist and internal medicine physician in New York City. • Kidney Notes was the first active nephrology blog. (Trivia: Kidney Notes is so old that the National Library of Medicine still uses it as an example of how to formally cite blogs.) • Professionally, you can find me at Kidney.nyc. • Kidney Notes is for educational purposes only, not medical advice. Consult qualified health care professionals. See disclaimer.
Friday, November 11, 2005
First-Time Generic Approvals: Amaryl, Norvasc, Altace
Via Medscape: